- Report
- June 2025
- 89 Pages
North America
From €2998EUR$3,450USD£2,613GBP
- Report
- June 2025
- 81 Pages
Middle East, Africa
From €2998EUR$3,450USD£2,613GBP
- Report
- June 2025
- 97 Pages
Asia Pacific
From €3432EUR$3,950USD£2,992GBP
- Report
- June 2025
- 100 Pages
Europe
From €3432EUR$3,950USD£2,992GBP
- Report
- June 2025
- 90 Pages
United States
From €1737EUR$1,999USD£1,514GBP
- Report
- February 2025
- 95 Pages
North America
From €5209EUR$5,995USD£4,541GBP
- Report
- February 2025
- 111 Pages
Europe
From €5209EUR$5,995USD£4,541GBP
- Report
- February 2025
- 107 Pages
Asia Pacific
From €5209EUR$5,995USD£4,541GBP
- Report
- November 2023
- 127 Pages
Global
From €3910EUR$4,500USD£3,409GBP
- Report
- August 2020
- 250 Pages
Saudi Arabia
From €2033EUR$2,340USD£1,773GBP
€3128EUR$3,600USD£2,727GBP
- Report
- January 2023
- 127 Pages
Global
From €1955EUR$2,250USD£1,704GBP
- Report
- April 2021
Global
From €782EUR$900USD£682GBP
- Report
- March 2022
- 260 Pages
Global
From €3259EUR$3,750USD£2,841GBP
- Report
- February 2024
- 78 Pages
Global
From €2563EUR$2,950USD£2,235GBP
- Report
- February 2020
- 237 Pages
Global
From €2390EUR$2,750USD£2,083GBP
- Report
- February 2024
- 158 Pages
Global
From €4041EUR$4,650USD£3,522GBP
- Report
- August 2023
- 336 Pages
Global
From €4041EUR$4,650USD£3,522GBP
- Report
- January 2020
- 54 Pages
Global
From €1716EUR$1,975USD£1,496GBP
- Report
- December 2022
- 66 Pages
Global
From €3041EUR$3,500USD£2,651GBP
- Report
- February 2025
- 153 Pages
Global
From €5170EUR$5,950USD£4,507GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more